Wills Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.56M Buy
1,345
+30
+2% +$35.4K 0.55% 44
2026
Q2
$1.58M Buy
1,315
+296
+29% +$302K 0.57% 43
2026
Q1
$1.03M Buy
1,019
+181
+22% +$183K 0.39% 47
2025
Q4
$901K Buy
838
+139
+20% +$133K 0.34% 48
2025
Q3
$533K Buy
+699
New +$520K 0.22% 49

Other funds holding LLY

Wills Financial Group's LLY Position: Q3 2026 in Review

Wills Financial Group increased its Eli Lilly (LLY) stake by 2.3% in Q3 2026, buying an estimated $35.4K and bringing the position to 1,345 shares worth $1.56M. The position accounts for 0.55% of the portfolio, ranked #44.

Wills Financial Group first reported a position in LLY in Q3 2025 and has held it in 5 quarters since. The position peaked at $1.58M in Q2 2026. 4,624 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Wills Financial Group held 1,345 shares of Eli Lilly worth $1.56M as of Q3 2026.
  • Wills Financial Group bought 30 Eli Lilly shares in Q3 2026, an estimated $35.4K.
  • Eli Lilly made up 0.55% of Wills Financial Group's portfolio in Q3 2026, its #44 holding.
  • Wills Financial Group first reported a position in Eli Lilly in Q3 2025 and has held it in 5 quarters since.
  • Wills Financial Group's Eli Lilly position peaked at $1.58M in Q2 2026.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Wills Financial Group's 13F filing for Q3 2026, filed 12 Nov 2026.